TCG Crossover Management LLC 13D/13G Filings for Cogent Biosciences, Inc. (COGT)

TCG Crossover Management LLC 13D and 13G filings for Cogent Biosciences, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2021-11-17
3:39 pm
Purchase		 2021-11-05 13G Cogent Biosciences, Inc.
COGT		 TCG Crossover Management LLC 2,716,042
6.800%		 706,054increase
(+35.13%)		 Filing
2021-07-08
1:50 pm
Purchase		 2021-06-28 13G Cogent Biosciences, Inc.
COGT		 TCG Crossover Management LLC 2,009,988
5.200%		 2,009,988increase
(New Position)		 Filing